| Literature DB >> 24098729 |
Bin Li1, Yongfei Hu, Qi Wang, Yong Yi, Patrick C Y Woo, Hua Jing, Baoli Zhu, Cui Hua Liu.
Abstract
BACKGROUND: Klebsiella pneumoniae strains carrying class 1 integrons are becoming more common worldwide, and their role in the dissemination of drug resistance is significant. The aim of this study was to characterize the structural diversity of class 1 integrons and their associated gene cassettes in K. pneumoniae isolates from hospital settings. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2013 PMID: 24098729 PMCID: PMC3786929 DOI: 10.1371/journal.pone.0075805
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of class 1 integrons and their associated gene cassette arrays from 70 isolates (one of the isolates has two intergrons).
|
|
|
|
|
|
|---|---|---|---|---|
| I (24) |
| 1171 | Trimethoprim | JQ823008 |
| II (12) |
| 1602 | Trimethoprim, streptomycin, spectinomycin | JQ823009 |
| III (10) |
| 1851 | Trimethoprim, streptomycin, spectinomycin | JQ823010 |
| IV (10) |
| 1391 | Trimethoprim, Fluoroquinolone | JQ823011 |
| V (4) |
| 1011 | Streptomycin, spectinomycin | JQ823012 |
| VI (4) |
| 1519 | Trimethoprim, streptomycin, spectinomycin | JQ823013 |
| VII (3) |
| 1466 | Fluoroquinolone, rifampicin | JQ823014 |
| VIII (2) |
| 719 | Trimethoprim | JQ823015 |
| IX (1) |
| 966 | Streptomycin, spectinomycin | JQ823016 |
| X (1) | ORF for hypothetical protein, | 812 | Unknown | JQ823017 |
partial gene.
Figure 1Schematic representation of the variable regions of class 1 integrons identified in .
Integron type with different cassette arrays (type I to X) are arranged as identified in Table 1. Gene cassettes are shown as boxes, with arrows indicating the orientation of transcription and hollow circles indicating the 59-base elements. The 5’- and 3’-conserved segments (5’-CS and 3’-CS) are annotated.
Figure 2Comparison of the type IV integron in this study with its homologue in database.
Sequence of E. coli strain DJ33-7 class I integron (JF806489) was retrieved from NCBI. The type IV integron (JQ823011) is arranged as indicated in Table 1. Gene cassettes are shown as boxes, with arrows indicating the orientation of transcription. The 5’- and 3’-conserved segments (5’-CS and 3’-CS), attC, attI sites are annotated. Dashed box indicates a 590-bp deletion in the type IV integron.
Rates of drug resistance among 176 isolates with and without class 1 integrons.
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| Antimicrobial categories | With resistance to single drugs | |||||
| Cephalosporins | Cefazolin | 28/90 (31.1) | 62/90 (68.9) | 60/86 (69.8) | 26/86 (30.2) | <0.001 |
| Ceftriaxone | 29/90 (32.2) | 61/90 (67.8) | 61/86 (70.9) | 25/86 (29.1) | <0.001 | |
| Ceftazidime | 30/90 (33.3) | 60/90 (66.7) | 59/86 (68.6) | 27/86 (31.4) | <0.001 | |
| Cefepime | 29/90 (32.2) | 61/90 (67.8) | 61/86 (70.9) | 25/86 (29.1) | <0.001 | |
| Aminoglycosides | Gentamicin | 34/90 (37.8) | 56/90 (62.2) | 66/86 (76.7) | 20/86 (23.3) | <0.001 |
| Tobramycin | 26/90 (28.9) | 64/90 (71.1) | 63/86 (73.3) | 23/86 (26.7) | <0.001 | |
| Amikacin | 59/90 (65.6) | 31/90 (34.4) | 74/86 (86.0) | 12/86 (14.0) | 0.002 | |
| Streptomycin | 61/90 (67.8) | 29/90 (32.2) | 86/86 (100.0) | 0 | <0.001 | |
| Aminocyclitol antibiotic | Spectinomycin | 64/90 (71.1) | 26/90 (28.9) | 86/86 (100.0) | 0 | <0.001 |
| Carbapenems | Imipenem | 83/90 (92.2) | 7/90 (0.8) | 84/86 (97.7) | 2/86 (2.3) | 0.101 |
| Ertapenem | 82/90 (91.1) | 8/90 (0.9) | 81/86 (94.2) | 5/86 (5.8) | 0.436 | |
| Fluoroquinolones | Ciprofloxacin | 39/90 (43.3) | 51/90 (56.7) | 66/86 (76.7) | 20/86 (23.3) | <0.001 |
| Levofloxacin | 40/90 (44.4) | 50/90 (55.6) | 67/86 (77.9) | 19/86 (22.1) | <0.001 | |
| Folate pathway inhibitors | Trimethoprim | 21/90 (23.3) | 69/90 (76.7) | 60/86 (69.8) | 26/86 (30.2) | <0.001 |
| Cephamycins | Cefotetan | 34/90 (37.8) | 56/90 (62.2) | 20/86 (23.3) | 66/86 (76.7) | 0.037 |
| Nitrofuran antibiotcs | Nitrofurantoin | 9/90 (10.0) | 81/90 (90.0) | 15/86 (17.4) | 71/86 (82.6) | 0.150 |
| Penicillins | Ampicillin | 0 | 90/90 (100.0) | 0 | 86/86 (100.0) | ND [ |
| Antipseudomonal penicillins+beta-lactamase inhibitors | Piperacillin/Tazobactam | 57/90 (63.3) | 33/90 (36.7) | 78/86 (90.7) | 8/86 (9.3) | <0.001 |
| Penicillins+beta-lactamase inhibitors | Ampicillin/Sulbactam | 30/90 (33.3) | 60/90 (66.7) | 60/86 (69.8) | 26/86 (30.2) | <0.001 |
| Ansamycins | Rifampicin | 87/90 (96.7) | 3/90 (3.3) | 86/86 (100.0) | 0 | 0.088 |
| Monobactams | Aztreonam | 28/90 (31.1) | 62/90 (68.9) | 62/86 (72.1) | 24/86 (27.9) | <0.001 |
| Drug resistance types | ||||||
| MDR | 36/90 (40.0) | 54/90 (60.0) | 32/86 (37.2) | 54/86 (62.8) | 0.704 | |
| XDR | 62/90 (68.9) | 28/90 (31.3) | 76/86 (88.4) | 10/86 (11.6) | 0.002 | |
| PDR | 89/90 (98.9) | 1/90 (1.1) | 84/86 (97.7) | 2/86 (2.3) | 0.534 | |
| Other types | 83/90 (92.2) | 7/90 (7.8) | 66/86 (76.7) | 20/86 (23.3) | 0.004 | |
| ESBL production | 33/90 (36.7) | 57/90 (63.3) | 63/86 (73.3) | 23/86 (26.7) | <0.001 | |
ND: No data.